The January 2015 Harvard Women’s Health Watch discusses the new mammography guidelines from the U.S. Preventive Services Task Force (USPSTF) and what they mean for female patients.
February 5, 2016 — StatRad, provider of cloud-based medical image exchange technology and teleradiology services, is supporting critical diagnostic health services at Tenwek Hospital in rural western Kenya through donated RadConnect software services.
New research may allow more effective and safer pain medications to reach patients who suffer from chronic pain sooner. According to a recent study published in Anesthesiology, the official medical journal of the American Society of Anesthesiologists (ASA), using functional magnetic resonance imaging (FMRI) to measure the brain’s neural response to pain may be a viable tool for evaluating the effectiveness of new pain medications during the early stages of human drug development. This could provide the needed objective evidence to prevent the premature discarding of potentially beneficial therapies.
RAD Technology Medical Systems (RAD) has added a new patent to its expanding portfolio of modular building technologies for cancer treatment facilities.
The American College of Radiology’s ACR 2016 annual meeting offers sessions on advanced data science tools, clinical decision support and electronic medical records (EMRs) optimization to help radiology professionals support enterprise imaging initiatives and adapt to new alternative payment models.
Akrotome Imaging Inc. received a major award from the National Institutes of Health (NIH) in November to complete development and commercialization of its new imaging platform.
The widespread belief that radiation from X rays, CT scans and other medical imaging can cause cancer is based on an unproven, decades-old theoretical model, according to a study published in the American Journal of Clinical Oncology.
The University of Maryland School of Medicine (UM SOM) announced the establishment of the Maryland Proton Alliance (MPA), a new organizational framework for proton therapy that may serve as a national model for patient-centered cancer care.
